A Safety And Pharmacokinetic Study With CVX-045 In Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

March 31, 2009

Study Completion Date

November 30, 2010

Conditions

Advanced Solid TumorsNeoplasmsCarcinomaCancerMalignancy

Interventions

BIOLOGICAL

CVX-045

Weekly, intravenous dose

Trial Locations (3)

Pfizer Investigational Site, Philadelphia

Pfizer Investigational Site, Scottsdale

Pfizer Investigational Site, Santa Monica